Gujarat Themis Biosyn Share Price | Gujarat Themis Biosyn Stock Screener
GUJTHEM
Pharmaceuticals
Share Price NSE
₹356.30
▲
4.80 (1.37%)
Share Price BSE
₹355.30
▲
3.55 (1.01%)
As of July 23, 2026, the Gujarat Themis Biosyn share price (NSE: GUJTHEM) is ₹356.30 on NSE and ₹355.30 on BSE, up 1.37% from the previous close, with shares trading between ₹346.50 and ₹366.90, and a 52-week range of ₹226.90–₹469.90.
Analyse GUJTHEM price trends and track historical price performance.
Use the Gujarat Themis Biosyn stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Gujarat Themis Biosyn Market Cap
₹4,027.36 Cr.
GUJTHEM P/E Ratio (TTM)
86.66
Gujarat Themis Biosyn P/B Ratio
14.04
EPS (TTM)
₹4.28
Dividend Yield
0.18%
Debt to Equity
0.07
GUJTHEM 52 Week High
₹469.90
Gujarat Themis Biosyn 52 Week Low
₹226.90
Operating Margin
46.00%
Profit Margin
30.72%
GUJTHEM Revenue (TTM)
₹166.00
EBITDA
₹76.00
Net Income
₹51.00
Total Assets
₹503.00
Total Equity
₹288.00
Gujarat Themis Biosyn Share Price Chart
Screen Gujarat Themis Biosyn share price with an interactive chart. Analyse GUJTHEM price trends and volatility across different timeframes.
Gujarat Themis Biosyn Company Profile - Fundamental Screener
Screen Gujarat Themis Biosyn company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GUJTHEM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE942C01045
Gujarat Themis Biosyn Balance Sheet Screener
Screen GUJTHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 503 | 301 | 221 | 166 | 123 | 88 | 64 | 33 | 21 | 21 |
| Current Assets | 89 | 52 | 48 | 62 | 78 | 63 | 29 | 8 | 8 | 8 |
| Fixed Assets | 410 | 41 | 38 | 33 | 19 | 19 | 17 | 15 | 11 | 11 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 137 | 32 | 4 | 2 | 2 | 3 | 5 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 288 | 248 | 201 | 149 | 103 | 70 | 42 | 19 | 12 | 8 |
| Share Capital | 11 | 11 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 277 | 238 | 194 | 142 | 96 | 63 | 35 | 11 | 5 | 1 |
Gujarat Themis Biosyn Income Statement Screener - Profit & Revenue Analysis
Screen Gujarat Themis Biosyn income statement and profit fundamentals.
Analyze GUJTHEM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Gujarat Themis Biosyn share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 166 | 153 | 174 | 155 | 119 | 94 | 87 | 43 | 39 | 36 | 33 | 32 |
| Expenses | 90 | 81 | 91 | 75 | 57 | 50 | 53 | 34 | 33 | 30 | 27 | 25 |
| EBITDA | 76 | 71 | 83 | 80 | 62 | 44 | 34 | 10 | 6 | 6 | 6 | 6 |
| Operating Profit % | 46.00% | 46.00% | 46.00% | 50.00% | 51.00% | 45.00% | 37.00% | 18.00% | 16.00% | 17.00% | 19.00% | 20.00% |
| Depreciation | 13 | 5 | 4 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 3 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 62 | 66 | 79 | 78 | 59 | 41 | 31 | 8 | 5 | 5 | 5 | 5 |
| Tax | 11 | 17 | 20 | 20 | 15 | 11 | 8 | 2 | 1 | 1 | 0 | 0 |
| Net Profit | 51 | 49 | 59 | 58 | 44 | 30 | 24 | 6 | 4 | 4 | 5 | 5 |
| EPS | 4.28 | 4.48 | 40.72 | 39.90 | 30.03 | 20.77 | 16.30 | 4.41 | 2.66 | 3.01 | 3.19 | 3.16 |
Gujarat Themis Biosyn Cash Flow Screener - Liquidity Fundamentals
Screen GUJTHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 91 | 64 | 40 | 40 | 11 | 1 | 1 | 6 | 3 | 4 |
| Investing Activities | -112 | -55 | -20 | -30 | -2 | -3 | -6 | -1 | -3 | -1 |
| Financing Activities | 26 | -9 | -13 | -14 | -5 | 2 | 5 | -4 | 0 | -3 |
| Net Cash Flow | 5 | 0 | 6 | -4 | 3 | 0 | 0 | 1 | 0 | 0 |
Gujarat Themis Biosyn Shareholding Pattern Screener
See Gujarat Themis Biosyn shareholding pattern with promoter, FII, and DII holdings.
Check Gujarat Themis Biosyn promoter holding and ownership changes for GUJTHEM on TickJournal.
| Item | 2026-Mar | 2025-Feb | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% |
| FII Holding | 1.80% | 0.00% | 1.91% | 2.51% | 2.95% | 1.96% | 1.05% | 1.44% |
| DII Holding | 1.18% | 1.16% | 1.17% | 1.17% | 1.17% | 1.17% | 0.82% | 1.18% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.88% | 19.75% | 19.66% | 19.31% | 18.72% | 19.90% | 22.26% | 21.17% |
| Other Holding | 6.28% | 8.22% | 6.39% | 6.14% | 6.29% | 6.10% | 5.00% | 5.35% |
| Shareholder Count | 26,886 | 30,695 | 30,673 | 28,945 | 28,319 | 27,325 | 29,576 | 30,280 |
Gujarat Themis Biosyn Share Dividend Screener - Share Yield Analysis
Check Gujarat Themis Biosyn dividend history with payout and yield data.
View Gujarat Themis Biosyn dividend details including ex-dates and amounts for GUJTHEM stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.67 | 0.30% |
| 2024-March | ₹1.00 | 0.35% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Gujarat Themis Biosyn Stock Index Membership
See which indices include Gujarat Themis Biosyn stock.
Check GUJTHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE INDEX BSE HC
BSE INDEX SMLCAP
Gujarat Themis Biosyn Market Events Screener - Corporate Actions
Get Gujarat Themis Biosyn corporate actions including splits, bonuses, and buybacks.
Check Gujarat Themis Biosyn stock events that may affect GUJTHEM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 6.10% |
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 6.98% |
| 2025-11-10 | 2025-11-10 | Quarterly Result Announcement | NA | -2.76% |
| 2025-09-12 | 2025-09-12 | Annual General Meeting | NA | 5.18% |
| 2025-09-04 | 2025-09-05 | Dividend | ₹ 0.67 /share | 14.14% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 7.60% |
| 2025-05-20 | 2025-05-20 | Quarterly Result Announcement | NA | 6.23% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -12.92% |
| 2024-10-25 | 2024-10-25 | Quarterly Result Announcement | NA | -7.92% |
| 2024-08-09 | 2024-08-09 | Bonus | 1:2 | 3.18% |
| 2024-07-23 | 2024-07-23 | Annual General Meeting | NA | 15.98% |
| 2024-07-15 | 2024-07-16 | Dividend | ₹ 0.25 /share | 20.54% |
| 2024-02-22 | 2024-02-22 | Dividend | ₹ 0.75 /share | -2.29% |
| 2023-10-10 | 2023-05-13 | Split | 1:5 | 0.00% |
| 2023-09-01 | 2023-09-02 | Dividend | ₹ 1.00 /share | 1.31% |
Gujarat Themis Biosyn Competitors Screener - Peer Comparison
Screen GUJTHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 463,695 | 40.65 | 61,674 | 12.69% | 11,565 | 62.67 |
| Divis Laboratories | 192,398 | 75.67 | 10,560 | 8.73% | 2,520 | 69.61 |
| Torrent Pharmaceuticals | 181,169 | 79.18 | 13,886 | 20.34% | 2,138 | 53.08 |
| Zydus Life Science | 115,083 | 22.46 | 27,658 | 17.64% | 5,026 | 59.19 |
| Cipla | 114,609 | 29.90 | 29,045 | 2.24% | 3,870 | 48.42 |
| Lupin | 111,711 | 21.34 | 29,039 | 26.75% | 5,356 | 54.70 |
| Mankind Pharma | 102,596 | 54.23 | 14,636 | 14.85% | 1,938 | 50.34 |
| Dr Reddys Laboratories | 101,095 | 24.57 | 35,059 | 3.90% | 4,158 | 31.90 |
| Aurobindo Pharma | 88,228 | 25.67 | 33,385 | 3.21% | 3,376 | 50.49 |
| Laurus Labs | 82,587 | 94.51 | 6,868 | 22.01% | 890 | 59.60 |
Gujarat Themis Biosyn Company Announcements - News Screener
Screen GUJTHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-21 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-07-21 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-21 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-19 | Updates on revised Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-17 | Announcement Under Regulation 30 (LODR) - Updates On Arbitration Matter. | - |
| 2026-07-14 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-07-14 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-07-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-14 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-07-14 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-07-04 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-04 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | - |
| 2026-07-02 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-02 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-01 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-01 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-29 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-06-26 | Announcement Under Regulation 30 (LODR)-Updates | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-24 | Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011 | - |